Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma

Condition:   T-Cell Lymphoma Relapsed & Refractory Interventions:   Drug: Copanlisib;   Drug: Romidepsin Sponsors:   Changchun Deng;   Bayer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials